DaVita Stock Price and Value Analysis

Should you buy DaVita stock? (NYSE:DVA). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
  • This company is very stable.
  • This stock is on sale.
  • This company is making money at a modest rate.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the DVA Numbers

DVA Price
(DaVita stock price per share)
$72.99
[?] DVA Fair Price
(based on intrinsic value)
$88.46
[?] DVA Safety Price (based on a variable margin of safety) $70.77
[?] PE Ratio versus Sector 44% lower than other Healthcare stocks
[?] PE Ratio versus Industry 16% higher than other Unknown stocks
[?] Cash Yield 20.03%
[?] Free Cash Flow Jitter 40%

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 3,696,526 shares shorted. With 90,166,054 shares available for purchase and an average trading volume over the past 10 trading days of 544,120, it would take at least 6.794 days for all of the short holders to cover their shorts.

Is DaVita Stock on Sale?

We believe that DaVita may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

DaVita looks like a price in the fair value range. Based on our analysis—if the company keeps making money the way it has been—you could be looking at a good stock. See Before You Buy for your next steps.

Should You Buy DVA Stock?

Does DaVita have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.